GOLDMAN SACHS GROUP INC - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 109 filers reported holding CYTEK BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$2,971,719
-38.8%
538,355
-5.3%
0.00%0.0%
Q2 2023$4,854,093
+157.5%
568,395
+177.1%
0.00%
Q1 2023$1,885,182
-49.0%
205,134
-43.4%
0.00%
-100.0%
Q4 2022$3,697,266
+155.2%
362,122
+267.7%
0.00%
Q3 2022$1,449,000
+80.4%
98,478
+31.5%
0.00%
Q2 2022$803,000
-88.5%
74,892
-88.5%
0.00%
-100.0%
Q1 2022$7,000,000
+614.3%
649,289
+981.1%
0.00%
Q4 2021$980,000
-34.0%
60,060
-13.4%
0.00%
Q3 2021$1,484,00069,3220.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Brown Capital Management 13,560,480$74,853,8501.15%
HHLR ADVISORS, LTD. 6,657,030$36,746,8060.82%
RA Capital Management 6,809,404$37,587,9100.74%
Versor Investments LP 33,900$187,1280.04%
SHERBROOKE PARK ADVISERS LLC 15,656$86,4210.03%
NEW YORK STATE COMMON RETIREMENT FUND 2,348,015$12,9610.02%
Quantbot Technologies LP 46,452$256,4150.02%
Grandeur Peak Global Advisors, LLC 33,131$182,8830.01%
SG Americas Securities, LLC 188,813$1,0420.01%
NorthCrest Asset Manangement, LLC 52,050$287,3160.01%
View complete list of CYTEK BIOSCIENCES INC shareholders